Press Coverage

Neurosurgeons identify malign tumors with Cellvizio optical biopsy

11 September 2015

A team of neurosurgeons in Germany has used the Cellvizio optical biopsy system to identify cancerous brain and spinal tumors in real time, suggesting that the technology could be used for immediate diagnosis in future operations to improve surgical outcomes and patient recovery.

Latest News

Mauna Kea Technologies Announces New Positive Clinical Results for Cellvizio in Food Intolerance

Mauna Kea Technologies Announces New Positive Clinical Results for Cellvizio in Food Intolerance

Mauna Kea Technologies Reports H1 2024 Financial Results and Q3 2024 Sales

Mauna Kea Technologies Reports H1 2024 Financial Results and Q3 2024 Sales

Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio 

Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio